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ers (CRS-1 and CRS-2) were investigated. Abnormal CRS-1 was defined as abnormal
PLF or abnormal TS only when PLF was not analysable. Abnormal CRS-2 was defined
as abnormal TS or abnormal PLF only when TS was not analysable. 
Results: There were 295 patients with LVEF < 30% in the placebo arm of EMIAT trial of
those 57 died during mean follow-up of 22 months. The mortality of 19.3% was compara-
ble to that in conventional-therapy group in MADIT II trial (19.8%). Prediction results are
shown in the Table. CRS-1 stratification associated with sensitivity of 49% would reduce
the costs of defibrillator therapy to 23%. CRS-2 stratification associated with sensitivity of
68% would reduce the costs of defibrillator therapy to 39%.
Conclusion: As MADIT II indication criteria for defibrillator therapy are not fully imple-
mented due to the lack of financial resources, the selection of patients at the highest risk
with acceptable sensitivity using Holter-based risk stratifiers might be of considerable
clinical value.
1015-218 Value of Electrocardiographic Parameters in Identifying 
Patients With a Mild Form of Arrhythmogenic Right 
Ventricle Dysplasia
Khurram Nasir, Chandra Bomma, Darshan Dalal, Daniyal Ahmed, HariKrishna Tandri, 
Ariel Roguin, Cynthia James, Crystal Tichnell, Hugh Calkins, Johns Hopkins Medical 
Institutions, Baltimore, MD
Background: Although overt forms of ARVD are easily identified, it is difficult to differen-
tiate patients with a mild form of ARVD who have minimal involvement of the right ventri-
cle from those with idiopathic ventricular tachycardia (IVT). The aim of our study was to
identify electrocardiographic (ECG) criteria that best distinguish early ARVD from IVT.
Methods & Results: After excluding 19 patients with diffuse ARVD, the study population
consisted of 48 consecutive patients who presented with left bundle branch block (LBBB)
VT. Localized ARVD (n=20) was diagnosed based on the presence of regional RV
lesions, such as segmental RV wall motion abnormalities (hypo-akinetic or dyskinetic
areas), with mild or no ejection fraction reduction, whereas IVT (n=30) was classified
based on the exclusion of structural heart disease. Patients with localized ARVD com-
pared to IVT had a greater QRS duration in V1-V3 (113±14 vs.99±12 ms, p=0.0004), S
wave upstroke duration in V1-V3 (57±10 vs. 37±9 ms, p<0.0001), QRS dispersion (33±9
vs. 24±11 ms, p<0.02), and QT dispersion (67±18 vs. 37±14 ms, p<0.0001). The relative
prevalence of ECG abnormalities in these two conditions is shown in the table. An S
wave upstroke duration >55 ms in V1-V3 had the highest diagnostic value with a Chi-
square value of 36.7.
Conclusion: A delayed S wave upstroke in V1-V3 is the ECG parameter which best dif-
ferentiates mild ARVD from IVT, and might be considered as diagnostic ECG criteria for
ARVD.
1015-219 The Influence of Atrial and Ventricular Pacing on T Wave 
Alternans
Aneesh V. Tolat, Matthew R. Reynolds, Panos Papageorgiou, Allison W. Richardson, 
Peter Zimetbaum, Mark E. Josephson, Beth Israel Deaconess Medical Center, Boston, 
MA
Background: T Wave Alternans (TWA) is a novel technique of risk stratification for sud-
den cardiac death. Exercise and atrial pacing have been studied with regards to their
influence on TWA. In the present study, we investigated the differential effect of atrial and
atrioventricular pacing on TWA outcome (TWA-O) and TWA magnitude (TWA-M) and
examined their correlation with outcome of standard electrophysiology study (EPS) in
patients with coronary disease and left ventricular dysfunction. 
Methods: Atrial and atrioventricular pacing at 5 rates (80, 90, 100, 110, 115 bpm) for 1.5
minutes was performed followed by EPS in 34 patients with a history of coronary disease
and mean ejection fraction 28% referred for risk stratification. A Cambridge Heart, Heart-
wave system was used to analyze TWA-O (+ or - ) according to standard guidelines.
TWA analysis was based on recordings from 6 precordial leads and 4 orthogonal leads.
Results: Atrioventricular pacing resulted in higher TWA-M when compared to atrial pac-
ing alone, but both sites yielded similar TWA-O (p=0.02; Sign Test; kappa=0.61). Mono-
morphic ventricular tachycardia was inducible in 20/34 patients. TWA was positive in 16
patients during atrial pacing and in 13 patients during atrioventricular pacing but TWA-O
did not correlate with EPS outcome. The ECG lead distribution of TWA was independent
of pacing site. Leads V2-V4 demonstrated 100% sensitivity for positive TWA
Conclusion: 1. Increased TWA-M during ventricular pacing suggests that ventricular
pacing may be proarrhythmic. 2. TWA and EPS measure different indices of electrical
instability and could be used in combination. 3. The use of the anterior precordial leads
may allow for a simplified approach in recording TWA. 4. Ventricular pacing may be alter-
native method to assess TWA in patients with atrial fibrillation. 
1015-220 Prevalence and Prognostic Implications of Transient ST-
Segment Elevation Early After Primary Angioplasty for 
ST-Segment Elevation Myocardial Infarction
Dan E. Hofsten, Kenneth Egstrup, Birgit Lund, Henning Molgaard, for the DANAMI-2 
investigators, Svendborg Hospital, Svendborg, Denmark, Skejby Sygehus, Aarhus 
University Hospital, Aarhus, Denmark
Background:Episodes of transient ST-segment elevation (STe) on Holter monitoring has
been associated with increased mortality after ST-segment elevation myocardial infarc-
tion (STEMI). However, previous studies all antedate the advent of primary angioplasty
(PA).
We compared the prevalence and prognostic implications of STe, detected early after
STEMI treated with fibrinolysis or PA respectively.
Methods: Holter monitoring was initiated at discharge from STEMI in 951 patients who
had been randomized to immediate revascularization with either fibrinolysis (n = 473) or
PA (n = 478) as part of the DANAMI-2 study. Significant STe was defined as an upward
shift of the ST segment > 0.2 mV in magnitude that lasted > 1 minute. Follow-up ranged
from 2 to 5 years. Primary end point was all-cause mortality.
Results:In the fibrinolysis group 48 (10.1%) had STe as compared to 26 (5.4%) in the PA
group (p = 0.007). Mortality in the fibrinolysis group was significantly higher among
patients with STe (hazard ratio: 4.1; p < 0.0001), and in a stepwise multivariate Cox
regression analysis incorporating clinical and investigational variables, STe was indepen-
dently correlated to outcome (p < 0.001). In the PA group however, none of the patients
with STe on Holter monitoring died during follow-up.
Conclusion: Immediate revascularization with PA in STEMI reduces the incidence of
subsequent STe as compared to fibrinolysis. Furthermore, unlike in fibrinolysed patients,
STe is not associated with increased mortality after PA. 
1015-221 Speed of QT Rate Adaptation Predicts Risk in 
Myocardial Infarction Survivors
Peter Smetana, Esther Pueyo, Katerina Hnatkova, Velislav Batchvarov, Marek Malik, St. 
George's Hospital Medical School, London, United Kingdom
Background: Descriptors of QT/RR relationship were reported repeatedly to provide
information superior to simple QTc interval. We therefore investigated the exact profile of
QT adaptation to changes in RR interval in Holter recordings of patients from the EMIAT
database.
Methods: In 866 (462 amiodarone (A), 404 placebo (P)) 24-hour Holter recordings
obtained 1 month after randomisation into EMIAT RR, and QT intervals were measured
automatically on a beat-to-beat basis using a commercial Holter system. The individual
QT rate adaptation profile was assessed on a continuous basis quantifying the weighted
impact of RR interval history on each measured QT interval. The speed of adaptation
was assessed by the so-called lambda factor (LF). The smaller the LF, the faster the QT/
RR adaptation (figure). The values of the LF were compared between survivors and
Prediction of all-cause mortality using CRS-1 and CRS-2
 CRS-1  CRS-2
 abnormal  normal  abnormal  normal
non-survivors
(absolute numbers) 28 29 39  18
survivors (absolute numbers)
 41  197  75  163
sensitivity (%)
 49.1 68.4
positive predictive value (%)
40.6 34.2
ECG Characteristics of ARVD vs. Idiopathic Ventricular Tachycardia
Localized 
ARVD
n=20
Idiopathic 
VTn=28
P value Ch- Square 
value
T wave inversion V1-V3 and 
beyond
14 (70%) 0 (-) <0.0001 27.6
Epsilon wave 3 (15%) 0 (-) 0.03 3.8
QRS>110 V1-V3 ms 10 (50%) 0 (-) <0.0001 17.7
QRS V1+V2+V3/ QRSd 
V4+V5+V6>1.2
12 (60%) 2 (7%) <0.0001 15.7
QRS dispersion>40 ms 7 (35%) 1 (4%) 0.004 8.3
QT dispersion>65 ms 12 (60%) 3 (10%) <0.0001 8.3
S wave upstroke>55 V1-V3 ms 18 (90%) 1 (4%) <0.0001 36.7
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patients who died during follow-up in both A and P treated patients separately.
Results: In both A and P arm, patients who died had significantly greater LF-values than
survivors (A 47.7± 11.0 vs 45.7± 7.5, p=0.03; P 53.6± 9.4 vs 48.8± 7.4, p<0.005). In both
survivors and those who died, LF-values on A were significantly smaller than on placebo
(p<0.005 in both comparisons). 
Conclusions: In high-risk post-MI patients, the QT interval adaptation to heart rate was
significantly slower than in survivors. An increase in adaptation speed on A might be an
explanation for the antiarrhythmic efficacy of the drug. 
1015-222 Electrocardiographic Progression of Arrhythmogenic 
Right Ventricular Dysplasia/Cardiomyopathy
Chandra Bomma, Jonathan Piccini, Darshan Dalal, Daniyal Ahmed, Harikrishna Tandri, 
Khurram Nasir, Crystal Tichnell, Cynthia James, Julie Rutberg, Hugh Calkins, Johns 
Hopkins University School of Medicine, Baltimore, MD
Back Ground: Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is a
genetic cardiomyopathy characterized by fatty fibrous replacement of right ventricle (RV).
Symptoms vary from ventricular arrhythmias to sudden cardiac death. The diagnosis of
ARVD/C is based on International Task Force criteria (TFC). Although ARVD/C is consid-
ered to be a progressive condition, few data are available concerning the rate and extent
of progression of this condition over time. The purpose of this study was to determine
whether serial electrocardiographic (ECG) evaluations demonstrate evidence of progres-
sion of ARVD/C.
Methods and Results: The study population included (32) individuals (13 males; mean
age 36±14 years) who were diagnosed with ARVD/C using the TFC. We analyzed the 12
lead ECG at two time points, separated by a median of 40 months. Progression on ECG
was defined as new T-wave inversion beyond the extent of T-wave inversion at baseline,
QRS progression of greater than 10 milliseconds duration over QRS duration at baseline,
development of a new bundle branch block (BBB), and/or the appearance of a new Epsi-
lon wave. Overall, ECG progression was observed in 20(62.5%) patients. T-wave pro-
gression was seen in 12(37.5%), QRS duration progression was seen in 4(12.5%)
patients and a new BBB was seen in 4(12.5%) patients. Epsilon wave was seen in one
patient and no new epsilon wave is seen in any of the patients.
Conclusion: The results of this study demonstrate that more than 50% of patients with
ARVD/C demonstrate evidence of progression of the disease by ECG criteria. Further
research is needed to determine what behavioral, clinical, and genetic factors best pre-
dict disease progression.
1015-223 T Wave Morphology Abnormalities Are Associated With 
Clinical Outcome in Hypertrophic Cardiomyopathy
Yi Gang, Katerina Hnatkova, Juan Gimeno, Marek Malik, St. George's Hospital Medical 
School, London, United Kingdom
Background: T-wave morphology (TWM) analysis quantifies repolarization abnormali-
ties. This study evaluated the relation of TWM to risk factors (RF: a family history of sud-
den cardiac death (SD), a history of VF, recurrent syncope, non-sustained VT, an
abnormal blood pressure response on exercise, maximum left ventricular wall thickness
>30 mm) for SD and clinical outcome in patients (pts) with hypertrophic cardiomyopathy
(HC).
Methods: Digitised 12-lead ECGs were recorded from 157 HC pts (107 men, age 43±15
yrs) using a MACVU electrocardiograph (GE Medical Systems, US) with a sampling rate
of 500 Hz. Study pts were followed up for 60±44 months. Analysis of the digital ECG
recordings was performed in a fully automatic manner with custom-developed software
implemented on a personal computer. Three TWM indices were calculated: complexity
ratio (CR), the total cosine R-to-T (TCRT), and relative T-wave residuum (TWR%).
Results: TWR% and CR were significantly increased in pts with any RF (0.14±0.02,
0.25±0.02) or with >2 RF (0.11±0.01, 0.23±0.02) compared with pts without any RF
(0.06±0.01, 0.20±0.01) (p<0.05, p<0.01), respectively. TCRT values were significantly
lower in pts with cardiac event (cardiac death, VF, ICD discharge) or cardiac death com-
pared with event-free survivors (table). A weak and significant correlation was found
between TCRT and maximum left ventricular wall thickness (r=-0.23, p=0.004).
Conclusion: Abnormalities in TWM are associated with RF or clinical outcome in HC
pts. 
1015-224 ST-Segment Elevation in Lead AVR in Acute Myocardial 
Infarction-Clue to Circumflex Coronary Artery Origin for 
Inferior/Posterior Myocardial Infarction
Chandana Weerasinghe, Giselle Smith, Mano Senaratne, Grey Nuns Hospital-University 
of Alberta, Edmonton, AB, Canada
Background: Inferior/posterior acute myocardial infarctions(AMI ) can result from occlu-
sion of the right or circumflex coronary arteries. Right pre-cordial and posterior leads are
often useful in this differentiation. The present study evaluated the utility of ST-segment
elevation (STE) in lead aVR in this differentiation.
Methods: ST-segment change (approximated to the nearest 0.5mm once a minimum of
0.5mm of deviation was identified) was measured with the naked eye on the presenting
electrocardiogram(EKG) in 561 consecutive pts with AMI (M=408, F=153; age: mean
64.8±0.6 yrs SEM). All the EKGs were evaluated by one individual who was blinded to
the rest of the clinical and investigational data. In all leads STE of 0.5 mm or more was
considered significant. All data were collected prospectively.
Results: 137 patients (24.4%) demonstrated STE in aVR with 17.3%, 26.4%, 38.7%, and
42.0% incidences in inferior, antero-septal, posterior, and lateral AMI’s respectively
(p<0.001). Those with STE in aVR had higher magnitudes of ST-segment depression
(STD) in leads I, II, V1, V2, V4, aVL and higher magnitudes of STE in leads II, III, aVF,
V5, V6 (p<0.01). The presence of STE in the right pre-cordial leads was not significantly
associated with STE aVR (p>0.05). In patients in whom an angiogram was done within
the hospital stay (138 pts=24.6%) STE in aVR was present in 15.4%, 30.8%, 52.4%, and
60.0% of patients with the culprit lesion in the right coronary, left anterior descending, cir-
cumflex, and obtuse marginal arteries respectively (p=0.003). STE in aVR appeared to
be associated with significantly lower creatine kinase peaks (1214±123 u/l vs. 1753±152
u/l, p=0.05) with a trend towards a lower in-hospital mortality (2.9% vs. 5.9%) and one-
year coronary event rates (18.7% vs. 28.1%, p=0.09).
Conclusions: STE in aVR is more often associated with inferior and/or posterior AMI’s
caused by a circumflex coronary artery occlusion (as opposed to a right coronary artery
occlusion). Thus, it may serve as a useful additional marker to help in this differentiation.
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1034-207 Mechanism for Rate Slowing by Anterior 
Atrioventricular Node Modification During Atrial 
Fibrillation: Partial Damage of the Compact Node 
Rather Than Fast Pathway Ablation
Youhua Zhang, Saroja Bharati, Rabi Sulayman, Todor N. Mazgalev, The Cleveland Clinic 
Foundation, Cleveland, OH, Hope Children's Hospital, Oak Lawn, IL
Background: We have demonstrated that selective fast pathway (FP) ablation has no
effect on ventricular rate (VR) in atrial fibrillation (AF). This appears to contradict reports
of VR slowing in about 1/3 of patients using anterior approach. We hypothesized that
such clinical outcome results from inadvertent damage of the compact atrioventricular
node (AVN).
Methods: His electrogram alternans (Circ 2003;107:1059) was used to monitor the dual
pathway conduction during AF in 12 rabbits. The FP conduction resulted in low amplitude
inferior His electrogram (IHE), while slow pathway (SP) - in high IHE. After successful
selective FP ablation, further lesions were applied progressively closer to the compact
AVN. The ablation sites were studied by detailed morphological sectioning.
Results: Both FP and SP conducted beats (Figure A, low and high IHE) were present
during AF. Selective FP ablation revealed only-SP conduction (B, high IHE), but didn’t
change VR (298±18 vs 301±14 bpm, P>0.05). Ablations closer to AVN resulted in SP-
rate slowing (C) and ultimately in AVN block (not shown). Morphological evidence indi-
cated that VR slowing occurred only when lesions extended into the compact AVN
domain resulting in a non-selective, FP plus SP, modification.
Conclusion: Selective FP ablation has no effect on VR in AF. Slower VR could be
TCRT (mean±sem) positive negative P value
Cardiac events (n=14) -0.67±0.09 –0.43±0.04 0.030
Cardiac death (n=9) -0.71±0.12 –0.43±0.04 0.035
